title: Imatinib resistance in chronic myeloid leukemia due to a rare mutation.
authors.affiliation: a Department of Laboratory Oncology , Dr. BRAIRCH, All India Institute of Medical Sciences , New Delhi , India.
authors.forename: Priyavadhana
authors.initials: P
authors.lastname: Balasubramanian
authors.affiliation: a Department of Laboratory Oncology , Dr. BRAIRCH, All India Institute of Medical Sciences , New Delhi , India.
authors.forename: Anita
authors.initials: A
authors.lastname: Chopra
authors.affiliation: a Department of Laboratory Oncology , Dr. BRAIRCH, All India Institute of Medical Sciences , New Delhi , India.
authors.forename: Deepak
authors.initials: D
authors.lastname: Verma
authors.affiliation: a Department of Laboratory Oncology , Dr. BRAIRCH, All India Institute of Medical Sciences , New Delhi , India.
authors.forename: Indresh K
authors.initials: IK
authors.lastname: Singh
authors.affiliation: b Department of Medical Oncology , Dr. BRAIRCH, All India Institute of Medical Sciences , New Delhi , India.
authors.forename: Akash
authors.initials: A
authors.lastname: Kumar
authors.affiliation: b Department of Medical Oncology , Dr. BRAIRCH, All India Institute of Medical Sciences , New Delhi , India.
authors.forename: Atul
authors.initials: A
authors.lastname: Sharma
authors.affiliation: a Department of Laboratory Oncology , Dr. BRAIRCH, All India Institute of Medical Sciences , New Delhi , India.
authors.forename: Rajive
authors.initials: R
authors.lastname: Kumar
mesh_terms: D000328:Adult; D000483:Alleles; D000970:Antineoplastic Agents / Q000494:pharmacology*; D045744:Cell Line, Tumor; D004252:DNA Mutational Analysis; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D016044:Fusion Proteins, bcr-abl / Q000737:chemistry / Q000235:genetics*; D006801:Humans; D000068877:Imatinib Mesylate / Q000494:pharmacology*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000235:genetics*; D008297:Male; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000494:pharmacology*
chemical_list: D000970:Antineoplastic Agents; D047428:Protein Kinase Inhibitors; D000068877:Imatinib Mesylate; D016044:Fusion Proteins, bcr-abl